Ensysce Biosciences Files 8-K

Ticker: ENSCW · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1716947

Ensysce Biosciences, INC. 8-K Filing Summary
FieldDetail
CompanyEnsysce Biosciences, INC. (ENSCW)
Form Type8-K
Filed DateApr 1, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, corporate-filing, financials

TL;DR

Ensysce Biosciences filed an 8-K on April 1, 2025, reporting routine corporate events and financials.

AI Summary

Ensysce Biosciences, Inc. filed an 8-K on April 1, 2025, reporting other events and financial statements. The company, formerly known as Leisure Acquisition Corp. until September 13, 2017, is incorporated in Delaware and headquartered in La Jolla, California.

Why It Matters

This filing indicates routine corporate reporting, including financial statements and other events, which is standard for publicly traded companies.

Risk Assessment

Risk Level: low — This is a standard 8-K filing reporting routine corporate events and financial statements, not indicating any immediate significant changes or risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of April 1, 2025.

When did Ensysce Biosciences, Inc. change its name?

Ensysce Biosciences, Inc. was formerly known as Leisure Acquisition Corp. and the date of the name change was September 13, 2017.

Where is Ensysce Biosciences, Inc. headquartered?

Ensysce Biosciences, Inc. is headquartered at 7946 Ivanhoe Avenue, Suite 201, La Jolla, California, 92037.

What is the company's state of incorporation?

The company is incorporated in Delaware.

What is the SIC code for Ensysce Biosciences, Inc.?

The Standard Industrial Classification (SIC) code for Ensysce Biosciences, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Ensysce Biosciences, Inc. (ENSCW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing